A similar effect is also observed during cancer progression, in which FSTL1 plays an important role in immune dysfunction regulating thymocyte maturation: in vivo inhibition of Fstl1 increases the tumour-specific CD8+ T-cell response [70]. This evidence concerns the gene FSTL1 and neoplasm.